This is an informative course on clinical trial development and regulatory considerations of drug development. However, I wish the course content is more updated and organized. The lecture videos are the just recordings from their classes in 2013.

I was looking for a course that would give me a general idea of drug development and that could help me fill in the gaps that I had on this subject. I found this course very interesting and useful. The only flaw: it could be more up to date.

Course materials are useful, lectures are very easy to understand, some of the video / sound editing is a bit unclear, since you can't see the presenter talk when the slides are being shown. Overall, a great intro to drug development.

Robust review of the intricacies of the clinical trial process and economic considerations throughout. My only regret is that the data is a bit dated (ending 2012/13) and I am curious to see how things have shifted since then.

The course started well. But the course about Phase 2 was difficult to digest. Even worst, the course about NDA was long, repetitive, with old data (as old as 2003 !) and some regulation from 2009 ! It need a serious update.

Overall, I liked this course. There are some improvements I would suggest: > list online resources more clearly > define acronyms and provide better definitions > quizzes need to be longer and slightly more challenging

The drug labeling seminar was not very informative. Both the presenters seemed to be wanting to go one-up on the other with their respective experiences. The entire session was too casual to be labeled as a lecture.

I would like to see more updated information (i.e. more information on biologicals), current presentation is a bit old (from 2008-2010?)

But it provides good general overview of the clinical development process.

I liked the content but I feel it wasn't very engaging and each slide had a lot of text. If there were peer review assignments and activities other than quizzes, the course would have been more interesting.

The course was informative and found exactly at the time of need. I was a little disappointed because it's not the latest updated version. looking forward to the updated version of the course.

It is really informative and nice to learn about such a vast and growing industry. The only complain I have is all the data was from 2012 which has now either been changed or updated.

The course should be updated. Most of the data presented is almost a decade old. Also, The person who teaches about Phase II trails is not clear, and it is hard to understand him.

I would have loved to have a specific case study to follow as an example of how a drug goes through the whole life cycle as the course felt a bit too high-level overview at times.

The course is well organized, but it requires an update of the contents.

It is good for starting and refreshing the topic of clinical trials. I look for the next updated one!

Very detailed and conceptually clear information. lectures are very well designed for online learning. Good distribution of the entire drug dev. procedure. Learnt a lot!

Provides a good overview on drug development phases and challenges. Some lecturers are from the industry which gives a practical feeling to the whole process.

Very well presented, very interesting. As many already mentioned unfortunately the material and data is a little out of date. Nevertheless, very good course.

Great Course , although i had some hardships understanding some parts and i had to search it online on my own ,, but overall i would recommend it !

i think you should put the speaker talking videos also in the lec not only the slides this will give more intent to complete the course faster

Week 3 was the best! Both lecturers had loads of experience in industry, and shared all that knowledge with practical and real-life examples.

It is an amazing course that provides an practical insight into the field of clinical research. Thank you so much for your help and support.

This course gives a wide overview about clinical trials and all the process needed to launch a new drug. I really enjoyed it.

one of the last pharmacist was terebal in explanation and her accent is unbelievable in bad way of course

Dr katie lyons

Good seminars , however talks need to be updated to 2022.

New challenges afetr COVID19 must be taking in consideration

Very informative content with lot of information about working of pharmaceutical companies during development of drugs.